This product is provided by the company SGM PHARMA SRL SOCIETA BENEFIT
. Please contact for more information.
Product Description
“A new generation of hyaluronic acid-based injectables featuring a
molecular architecture inspired by the natural gradients of the ocean”.
Nature does not rely on a single structure. In the marine world, structural diversity is not random, but a precise response to the surrounding physical environment.
The ocean is not uniform; each depth presents:
• different pressure
• different density
• different mechanical forces
TIADERM® follows the same biological principle, using specific viscoelastic matrices designed for each anatomical depth.
TEMPERATURE · INTEGRATION · ADHESION — TIA™ Technology
An engineered molecular architecture designed for precise injections, optimal tissue integration, and predictable clinical results.
T Temperature
Our patented slow, low-temperature cross-linking process ensures:
• Extended homogenization without compromising the HA polymer structure
• Controlled, gradual cross-linking
• Minimal BDDE content
• HA particles precisely sized from 1 to 20 microns
The outcome is a stable, homogeneous, and predictable 3D matrix, with each particle intentionally engineered for optimal performance.
I Integration
Cross-linked high-molecular-weight hyaluronic acid, combined with medium- and low-molecular-weight free HA, is integrated within the matrix, ensuring:
• Dynamic hydration
• Progressive biological modulation
• Sustained biological activity
The resulting 3D matrix remains active and adaptive, enabling the gradual, controlled release of free HA over time.
A ADHESION
Clinically relevant features:
• Seamless tissue integration
• Controlled plasticity
• Modulated elasticity
• Soft, natural feel
• No migration
By combining different molecular weights, particle morphology, and 3D organization, TIADERM® creates viscoelastic matrices specifically tailored to each clinical application.
“The ocean teaches us that depth determines structure.
TIA™ Technology demonstrates that molecular architecture drives predictable clinical behavior”